Laboratoire Hra Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LABORATOIRE HRA, and what generic and branded alternatives to LABORATOIRE HRA drugs are available?
LABORATOIRE HRA has two approved drugs.
Summary for Laboratoire Hra
US Patents: | 0 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Patent Litigation for Laboratoire Hra: | See patent lawsuits for Laboratoire Hra |
Drugs and US Patents for Laboratoire Hra
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Laboratoire Hra | LEVONORGESTREL | levonorgestrel | TABLET;ORAL | 204044-001 | Jul 3, 2018 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Laboratoire Hra | OPILL | norgestrel | TABLET;ORAL | 017031-001 | Approved Prior to Jan 1, 1982 | OTC | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Laboratoire Hra
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Laboratoire Hra | OPILL | norgestrel | TABLET;ORAL | 017031-001 | Approved Prior to Jan 1, 1982 | 3,666,858 | ⤷ Subscribe |
Laboratoire Hra | OPILL | norgestrel | TABLET;ORAL | 017031-001 | Approved Prior to Jan 1, 1982 | 3,959,322 | ⤷ Subscribe |
Laboratoire Hra | OPILL | norgestrel | TABLET;ORAL | 017031-001 | Approved Prior to Jan 1, 1982 | 3,850,911 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.